Results 71 to 80 of about 10,984 (251)

L-arginine therapy in Raynaud's phenomenon?

open access: yes, 1992
Since L-Arginine is the substrate for nitric oxide synthesis by vascular endothelial cells the effects of L-arginine treatment on the digital vascular response to local stimuli were investigated in patients with primary or secondary Raynaud's phenomenon.
B. Bottasso   +6 more
core   +1 more source

Efficacy of bosentan in the treatment of Raynaud’s phenomenon in patients with systemic sclerosis never treated with prostanoids

open access: yesReumatismo, 2014
The objective of this study was to evaluate the efficacy of the endothelin receptor antagonist, bosentan, in patients with Raynaud’s phenomenon secondary to systemic sclerosis never treated with prostanoids and without digital ulcers. The study design is
S. Parisi   +5 more
doaj   +1 more source

Laser Acupuncture on the Management of Xerostomia in Sjögren's Disease: A Randomized Clinical Trial

open access: yesOral Diseases, EarlyView.
ABSTRACT Objectives This study evaluated the efficacy of photobiomodulation (PBM) at acupuncture points for managing xerostomia in patients with Sjögren's Disease. Material and Methods In this randomized, double‐blind clinical trial, 50 patients were assigned to PBM group (n = 22) or sham‐PBM group (n = 28).
Matheus Ferreira Linares   +5 more
wiley   +1 more source

Endoscopic thoracic sympathicotomy for Raynaud's phenomenon

open access: yes, 2002
Purpose: For many years, thoracic sympathectomy via open surgery was not used to treat Raynaud's phenomenon because of the invasiveness of this procedure and the poor long-term outcomes associated with it.
Abe, Yoshinobu   +6 more
core   +1 more source

Novel Combination of UVA‐1 Phototherapy With Topical Tofacitinib for Treating Eosinophilic Fasciitis With Morphea: Case Report

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Eosinophilic fasciitis (EF) and morphea are rare sclerosing connective tissue disorders, and there remains debate about whether these entities are pathologically distinct or related. This case report describes the successful treatment of an adolescent patient who developed progressive morphea plaques while being treated with systemic ...
Daphne M. Cheung   +5 more
wiley   +1 more source

Sustained Remission of Pediatric Bowel‐Associated Dermatosis‐Arthritis Syndrome With Risankizumab

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT Bowel‐associated dermatosis‐arthritis syndrome (BADAS) is a rare neutrophilic dermatosis characterized by recurrent fever, arthralgias, and skin eruptions, most commonly occurring in patients with inflammatory bowel disease. We report the case of a 17‐year‐old female with Crohn's disease who developed BADAS and achieved complete and durable ...
Kylie E. Peake   +4 more
wiley   +1 more source

Motor Nerve Conduction Study in Raynaud's Phenomenon

open access: yes, 1986
The term Raynaud's phenomenon is the eponym of a clinical picture culmi nating into and dominated by accessorial vasomotor crysis which are triggered by different stimuli (cold, cigarette smoking, emotional stress); cold sensitivity however, is a rather ...
Cavallaro A.   +2 more
core   +1 more source

Botulinum toxin type A in the treatment of Raynaud's phenomenon

open access: yes, 2020
Raynaud's phenomenon is a vasospastic disorder clinically characterized by cold or stress-induced discoloration of the skin, pain and ulcers of the fingers or toes.
Vries-Bouwstra, J.K. de   +9 more
core   +1 more source

DRAMATIC RESPONSE TO OZONE APPLICATION: RAYNAUD'S PHENOMENON

open access: yes, 2021
Ozone application is used in medicine with many indications, vascular diseases are one of them. In this case report, the regression of ischemia-related complaints in the finger of a young female patient with Raynaud's Phenomenon after ozone application ...
Bal, Gülşah   +3 more
core   +1 more source

POS0850 NAILFOLD CAPILLARY DILATIONS IN RAYNAUD'S PHENOMENON: QUANTIFYING A PREDICTIVE THRESHOLD FOR THE ‘SCLERODERMA PATTERN‘ [PDF]

open access: bronze, 2021
Greta Pacini   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy